𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene

✍ Scribed by Wright, David J.; Earnhardt, J. Nicole; Perry, Richard; Bailey, Steven; Komm, Barry; Minck, Daniel R.; Cukierski, Mark A.

Book ID
118762715
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
360 KB
Volume
228
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Centchroman, a selective estrogen recept
Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders
✍ M.M. Singh πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 370 KB

DL-Centchroman (67/20; INN: Ormeloxifene) synthesized at the Central Drug Research Institute, Lucknow, is a nonsteroidal once-a-week oral contraceptive. It was introduced in Delhi in July, 1991, marketed in India in 1992 as Saheli and Choice-7 (Hindustan Latex Ltd., Thiruvananthapuram) and Centron (